Oral Dosage Form New Animal Drugs; Oxibendazole Suspension
other · Food and Drug Administration · Rule · Published 2006-06-08 · Effective 2006-06-08 · 71 FR 33237
Document
Document number
E6-8953
Federal Register citation
71 FR 33237
CFR reference
21 CFR 520
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
2006-06-08
Effective date
2006-06-08
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pfizer, Inc. The supplemental NADA provides for revised food safety labeling for oxibendazole suspension administered orally to horses as an antiparasitic.